Contineum Therapeutics, Inc. (CTNM)
13.44
-0.01
(-0.07%)
USD |
NASDAQ |
Apr 02, 16:00
13.47
+0.03
(+0.22%)
After-Hours: 20:00
Contineum Therapeutics Market Cap : 502.54M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Coherus Oncology, Inc. | 257.07M |
| ALX Oncology Holdings, Inc. | 259.27M |
| Century Therapeutics, Inc. | 370.57M |
| Climb Bio, Inc. | 295.77M |
| PepGen Inc. | 119.57M |
Market Cap Related Metrics
| PEG Ratio | -0.1858 |
| Price to Book Value | 1.926 |
| Price | 13.44 |
| Earnings Yield | -16.22% |
| PEGY Ratio | -0.1858 |